1. Market Research
  2. > Pharmaceutical Market Trends
  3. > India Pharmaceuticals and Healthcare Report Q1 2016

India Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 118 pages

Includes 3 FREE quarterly updates

BMI View:

India's pricing regime will continue to weigh on its pharmaceutical sector's growth potential.Affecting both local and multinational pharmaceutical firms, the price cuts can be substantial, therebycompounding the uncertainty created, especially as the decision process is carried out with limitedconsultation with the industry. Risks will also become more acute as the government looks to reform thepricing regime following the Supreme Court's verdict that existing prices are set at unreasonably highlevels.

Headline Expenditure ProjectionsPharmaceuticals: INR954bn (USD16bn) in 2014 to INR1,066bn (16bn) by 2015; +11.7% in localcurrency terms and 4.9% in US dollar terms.Healthcare: INR5,085bn (USD83bn) in 2014 to INR5,716bn (USD88bn) by 2015; +12.4% in localcurrency terms and 5.6% in US dollar terms.

Table Of Contents

India Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View ... 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (India 2013-2019) 7
SWOT 9
Industry Forecast .. 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2011-2019) . 13
Healthcare Market Forecast .. 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2011-2019) 19
Patented Drug Market Forecast . 20
Table: Selected Patent Developments Affecting Drugmakers 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2011-2019) 23
Generic Drug Market Forecast .. 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2011-2019) . 25
OTC Medicine Market Forecast . 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2011-2019) 27
Pharmaceutical Trade Forecast . 28
Table: Pharmaceutical Trade Data And Forecasts (India 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (India 2013-2019) 30
Industry Risk Reward Index . 31
Asia Pacific Risk/Reward Index .. 31
India Risk/Reward Index ... 38
Rewards ... 38
Risks 38
Regulatory Review 39
Pharmaceutical Advertising . 42
Pharmacovigilance . 42
Intellectual Property Issues .. 43
Table: History Of The Indian Patent System . 44
Table: A Series Of Setbacks For Innovative Pharmaceutical Firms . 45
Pricing Regime .. 49
Compulsory Licences .. 53
Market Overview ... 54
Healthcare Sector .. 54
Table: Healthcare Resources (India 2009-2014) . 57
Table: Healthcare Personnel (India 2009-2014) . 57
Table: Healthcare Activity (India 2009-2014) 58
Clinical Trials ... 60
Epidemiology 62
Table: Estimated Number Of New Cases Of Cancer In India 64
Competitive Landscape 65
Research-Based Industry . 65
Table: Ordinary Members Of OPPI 65
Table: Multinational Market Activity . 66
Generic Drug Industry 67
Key Industry Developments .. 67
Pharmaceutical Distribution 68
Pharmaceutical Retail Sector ... 69
Company Profile 70
Aurobindo Pharmaceutical 70
Cipla . 73
Dr. Reddy's Laboratories .. 77
GlaxoSmithKline . 81
Merck and Co 86
Novartis . 89
Pfizer 93
Ranbaxy Laboratories .. 97
Sanofi India .. 102
Sun Pharmaceutical ... 105
Demographic Forecast ... 107
Table: Population Headline Indicators (India 1990-2025) . 108
Table: Key Population Ratios (India 1990-2025) . 108
Table: Urban/Rural Population and Life Expectancy (India 1990-2025) . 109
Table: Population By Age Group (India 1990-2025) 109
Table: Population By Age Group % (India 1990-2025) . 110
Glossary ... 112
Methodology 114
Pharmaceutical Expenditure Forecast Model 114
Healthcare Expenditure Forecast Model ... 114
Notes On Methodology .. 115
Risk/Reward Index Methodology . 116
Index Overview 117
Table: Pharmaceutical Risk/Reward Index Indicators 117
Indicator Weightings 118

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.